Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Disease Markers"
DOI: 10.1155/2022/7902046
Abstract: Sclerostin is a secreted inhibitor of Wnt/β-catenin signaling that is mainly produced by osteocytes and is an important regulator of bone remodeling. Some studies have evaluated serum sclerostin levels in metabolic bone diseases, but the… read more here.
Keywords: serum sclerostin; bone; sclerostin; bone turnover ... See more keywords